NO960441D0 - Benzopyraner og farmasöytiske forbindelser inneholdende dem - Google Patents

Benzopyraner og farmasöytiske forbindelser inneholdende dem

Info

Publication number
NO960441D0
NO960441D0 NO960441A NO960441A NO960441D0 NO 960441 D0 NO960441 D0 NO 960441D0 NO 960441 A NO960441 A NO 960441A NO 960441 A NO960441 A NO 960441A NO 960441 D0 NO960441 D0 NO 960441D0
Authority
NO
Norway
Prior art keywords
benzopyrans
disease
compounds containing
compounds
pharmaceutical compounds
Prior art date
Application number
NO960441A
Other languages
English (en)
Norwegian (no)
Other versions
NO960441L (no
Inventor
Alexander Roderick Mackenzie
Sandra Marina Monaghan
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of NO960441L publication Critical patent/NO960441L/no
Publication of NO960441D0 publication Critical patent/NO960441D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO960441A 1993-08-04 1996-02-02 Benzopyraner og farmasöytiske forbindelser inneholdende dem NO960441D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans
PCT/EP1994/002387 WO1995004730A1 (en) 1993-08-04 1994-07-18 Benzopyrans and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
NO960441L NO960441L (no) 1996-02-02
NO960441D0 true NO960441D0 (no) 1996-02-02

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960441A NO960441D0 (no) 1993-08-04 1996-02-02 Benzopyraner og farmasöytiske forbindelser inneholdende dem

Country Status (28)

Country Link
US (2) US5912244A (es)
EP (1) EP0712398B1 (es)
JP (1) JP2871098B2 (es)
KR (1) KR0175532B1 (es)
CN (1) CN1128536A (es)
AT (1) ATE152716T1 (es)
AU (1) AU684817B2 (es)
CA (1) CA2168563C (es)
CO (1) CO4230234A1 (es)
CZ (1) CZ281853B6 (es)
DE (1) DE69403084T2 (es)
DK (1) DK0712398T3 (es)
EC (1) ECSP941140A (es)
EG (1) EG20525A (es)
ES (1) ES2102870T3 (es)
FI (1) FI960487L (es)
GB (1) GB9316111D0 (es)
GR (1) GR3023521T3 (es)
HU (1) HUT75120A (es)
IL (1) IL110488A (es)
NO (1) NO960441D0 (es)
NZ (1) NZ271344A (es)
PE (1) PE56894A1 (es)
PL (1) PL312788A1 (es)
SG (1) SG42817A1 (es)
TW (1) TW333532B (es)
WO (1) WO1995004730A1 (es)
ZA (1) ZA945774B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
JP3454832B2 (ja) * 1996-06-07 2003-10-06 バンダービルト ユニバーシティ 抗炎症剤として有用なジヒドロベンゾピランおよび関連化合物
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
RU2344123C9 (ru) * 2001-04-16 2009-05-20 Шеринг Корпорейшн 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора
CA2461381A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
KR20050074592A (ko) * 2002-11-12 2005-07-18 워너-램버트 캄파니 엘엘씨 벤조피란을 사용한 모발 성장의 자극 방법
BRPI0507669A (pt) * 2004-02-12 2007-07-17 Warner Lambert Co método para estimular crescimento de cabelo
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
WO2006008641A1 (en) * 2004-07-16 2006-01-26 Warner-Lambert Company Llc Hair growth promoting agents
BRPI0513401A (pt) * 2004-07-19 2008-05-06 Warner Lambert Co formulação para estimular crescimento de cabelo
JP4738418B2 (ja) * 2004-12-21 2011-08-03 エフ.ホフマン−ラ ロシュ アーゲー クロマン誘導体及びcns障害の処置におけるその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
ES2058148T3 (es) * 1987-02-04 1994-11-01 Hoechst Ag N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag, 6230 Frankfurt Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
TW244350B (es) * 1991-12-14 1995-04-01 Hoechst Ag
JPH0673061A (ja) * 1992-01-18 1994-03-15 Hoechst Ag 6−置換クロメン類のエナンチオ選択的エポキシ化方法

Also Published As

Publication number Publication date
FI960487A7 (fi) 1996-02-02
ECSP941140A (es) 1995-01-16
DK0712398T3 (da) 1997-10-27
CA2168563A1 (en) 1995-02-16
AU684817B2 (en) 1998-01-08
TW333532B (en) 1998-06-11
PE56894A1 (es) 1995-02-07
DE69403084T2 (de) 1997-08-14
US6071938A (en) 2000-06-06
DE69403084D1 (de) 1997-06-12
CN1128536A (zh) 1996-08-07
EP0712398B1 (en) 1997-05-07
CZ33196A3 (en) 1996-05-15
CO4230234A1 (es) 1995-10-19
CA2168563C (en) 1999-09-07
SG42817A1 (en) 1997-10-17
JPH08508042A (ja) 1996-08-27
NZ271344A (en) 1997-10-24
NO960441L (no) 1996-02-02
IL110488A (en) 1999-08-17
HUT75120A (en) 1997-04-28
IL110488A0 (en) 1994-10-21
FI960487A0 (fi) 1996-02-02
WO1995004730A1 (en) 1995-02-16
ATE152716T1 (de) 1997-05-15
AU7494894A (en) 1995-02-28
GR3023521T3 (en) 1997-08-29
US5912244A (en) 1999-06-15
ZA945774B (en) 1996-02-05
CZ281853B6 (cs) 1997-02-12
GB9316111D0 (en) 1993-09-22
PL312788A1 (en) 1996-05-13
EP0712398A1 (en) 1996-05-22
JP2871098B2 (ja) 1999-03-17
EG20525A (en) 1999-06-30
KR0175532B1 (ko) 1999-02-18
FI960487L (fi) 1996-02-02
ES2102870T3 (es) 1997-08-01

Similar Documents

Publication Publication Date Title
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
DK0889877T3 (da) Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
CA2210022A1 (en) Paroxetine hydrochloride solvates
PT882707E (pt) Novos compostos trciclicos e composicoes medicamentosas contendo os mesmos
BR0008015A (pt) Uso de um composto, composto, composições farmacêuticas, e, processo para preparar um composto
DK0712398T3 (da) Benzopyraner og farmaceutiske præparater, der indeholder dem
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
NO964180D0 (no) Tropanderivater, deres fremstilling og anvendelse
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
ATE225787T1 (de) Arylsubstituierte heterocyclische verbindungen
ATE399778T1 (de) Glucopyranosid, verfahren zu deren isolierung, pharmazeutische zusammensetzung und verwendung davon
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
DK0604355T3 (da) Arylsubstituerede heterocykliske forbindelser
NZ520155A (en) Thienopyridine derivatives, their production and use
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
DK0815109T3 (da) Fremgangsmåde til fremstilling af estere af anhydroecgonin
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application